The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Mr Investment, Oilex? Blimey. Even the name sounds like a geezer trying to sell you a broken watch from the inside of his jacket. Don't get us mixed up your other dodgy investments.
Difference
Novice I average around 37p so slight loss at the moment. I am happy where the company should be going they just aren't do us shareholders any favours.
How things are worded make a different wether the fundamentals have changed or not. It isn't good enough imo.
Elonmusk, we can take this up with them tomoz at the meeting. Are you trying to drop the price so I can get my 34p buy? ;)
It was a response to an email sent to the BOD its wasn't an acknowledgement of an an error. ODX is firmly on schedule to deliver on its objectives and that's my only concern. Every time there's a dip I'll buy more, so as far as I am concerned those jumping up and down over nothing this morning have done me a favour.
"Regulator - you are just clutching at straws and making excuses for what was, by general consensus, a poorly crafted RNS. My concern, as with other AIM companies, it that it's indicative of poor management. This comes not long after the Sky TV interview that also had to be clarified. I suspect he's out of his depth now."
Not now. He is not fit for the role. Period!
CB clearly you need to sell up as you are clearly dissatisfied with the direction this company is taking. Would it be a gain or loss ?
It's all good and well them acknowledging issues but it's happening too often. If nothing has changed with production capacity figures then why mention it? Especially in a shade of grey.
We knew they were looking to up capacity to 2m per week and the market did. Wording it the way they did in an RNS is a shower of ****e. It's starting to become unforgivable and I have to begin to wonder how many more of these blunders are going to come.
It isn't good enough and it's that simple in my eyes. They have repeatedly been told and addressed how poor PR is and that's how they continue to mess it up. It's a really frustrating hold because we should be much further along than we are.
Atb
Big lad...spot on
i think you`ve got to remember will Colin King that first and foremost he`s a scientist not a PR man. Whilst this company undoubtedly needs help with its PR, the proof will be in the orders or lack of them in August.
As for this BB this morning, what a laugh, panickers, bedwetters they`re all here, the bloke with the pregnant wife who`s sold his children to be in here!
I don`t believe all the hype here but I do believe the upside if it comes will be when the orders are released, if their good we`ll make money if not we will lose but it depends whether you`re willing to wait and give it a chance.
"Regulator - you are just clutching at straws and making excuses for what was, by general consensus, a poorly crafted RNS. My concern, as with other AIM companies, it that it's indicative of poor management. This comes not long after the Sky TV interview that also had to be clarified. I suspect he's out of his depth now."
Not at all. I'm reading it from the perspective of someone who works in healthcare and who does business with both Westminster and the devolved administrations. And as someone whose organisation needs to test thousands of staff each week...
"So if that was the contect (and it's not clear it is then why single out just Scotland, i.e. not NI & Wales). Whichever way ypou slice and dice it it's clumsy and inaccurate."
Simple - the Scottish government is more likely to plow its own furrow and want that to be known.
Potential for millions of tests per week...not too crappy
Still a crappy update, just a little less crappy.... Do they have a commercial person?
"Does CK also accept that Scotland is in the UK? tell him if not we'll move production to England and slap tariffs on Scotch."
Health is a devolved function. Any agreements on the purchase of tests will be done by the relevant devolved administrations. For England, it will be done by the UK government as there is no separate English administration. Hence the referenced to "the UK" and "Scotland".
Whilst I am in not doubt of the authenticity of the emails being shown, share holders (both II/PI) need it in an RNS. They have to submit a revised statement. And whoever fu*ked up needs to pay for the RNS cost
Thank you for posting the email communication. I am amazed anyone thought it would be anything other than a weekly estimate. They referred to weekly in previous emails.
Especially like this bit
"happy to confirm that it is gearing up manufacturing capacity for the Group to initially produce hundreds of thousands of tests a week, and this is expected to increase to 1.5m tests a week and potentially extended to 2m tests a week."
Good morning Paul,
I hope you are well. I was just looking for some clarity regarding the wording in today’s RNS:
"we are rapidly developing new tests, together with our partners, for COVID-19 that will need to be made and sold, ultimately, in the hundreds of thousands of units, if not millions."
Are these figures mentioned in a weekly scale like the previous RNS would suggest?
Thanks and kind regards,
*****
REPLY:
Hi *****,
Thanks for your email. I’m happy to clarify as below:
Clarification of COVID-19 production capacity
Omega has always taken a cautious approach to forecasting future potential sales for COVID-19 ahead of receipt commercial orders or supply agreements, which is reflective of the wording in today’s statement.
The Company has consistently referred to production expectations on a weekly basis and is happy to confirm that it is gearing up manufacturing capacity for the Group to initially produce hundreds of thousands of tests a week, and this is expected to increase to 1.5m tests a week and potentially extended to 2m tests a week.
Nothing has changed in terms these manufacturing capacity figures outlined in our most recent investor presentation and it is our aim to ensure that demand matches this capacity. Delivery of this will only be demonstrated through the signing of key supply agreements and through contracted orders, rather than just manufacturing capacity projections.
Kind regards,
Paul
Paul McManus
Managing Director